Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$158M |
| 2 |
Match Group
MTCH
|
+$112M |
| 3 |
Algonquin Power & Utilities
AQN
|
+$62M |
| 4 |
Adobe
ADBE
|
+$51M |
| 5 |
KKR & Co
KKR
|
+$46.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$486M |
| 2 |
PPLI
People Inc
PPLI
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$110M |
| 4 |
Alibaba
BABA
|
+$109M |
| 5 |
Fastly Inc
FSLY
|
+$85M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Healthcare | 12.99% |
| 3 | Consumer Discretionary | 12.41% |
| 4 | Financials | 12.09% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Immunovant
IMVT
$8.25B
| $206K | ﹤0.01% |
5,833
+1,685
| +41% | +$50.7K |
|
2352
Revolution Medicines
RVMD
$44B
| $206K | ﹤0.01% |
5,932
+2,971
| +100% | +$82.3K |
|
2353
ICF International
ICFI
$1.72B
| $205K | ﹤0.01% |
3,336
-807
| -19% | -$53.6K |
|
2354
Sonos
SONO
$1.85B
| $205K | ﹤0.01% |
13,534
-3,368
| -20% | -$49.6K |
|
2355
Workhorse Group
WKHS
$36.3M
| $205K | ﹤0.01% |
3
| – | – |
|
2356
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $201K | ﹤0.01% |
1,727
-219
| -11% | -$23.8K |
|
2357
Albertsons Companies
ACI
$5.83B
| $196K | ﹤0.01% |
14,130
+4,130
| +41% | +$60.3K |
|
2358
Nexa Resources
NEXA
$1.87B
| $196K | ﹤0.01% |
37,067
| – | – |
|
|
DHR.PRA
2359
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $196K | ﹤0.01% |
+133
| New | +$187K |
|
2360
Douglas Dynamics
PLOW
$1.02B
| $194K | ﹤0.01% |
5,662
-936
| -14% | -$34.6K |
|
|
KDMN
2361
DELISTED
Kadmon Holdings, Inc.
KDMN
| $194K | ﹤0.01% |
49,383
-5,743
| -10% | -$24.1K |
|
2362
VEON
VEON
$3.95B
| $193K | ﹤0.01% |
6,124
| – | – |
|
2363
Alphatec Holdings
ATEC
$1.44B
| $192K | ﹤0.01% |
28,832
-1,938
| -6% | -$10.9K |
|
|
AGNT
2364
AGNT Inc
AGNT
$734M
| $191K | ﹤0.01% |
9,506
+1,700
| +22% | +$26.2K |
|
2365
Arcus Biosciences
RCUS
$3.64B
| $191K | ﹤0.01% |
11,141
-320
| -3% | -$7.15K |
|
|
XRN
2366
Chiron Real Estate Inc
XRN
$477M
| $189K | ﹤0.01% |
2,799
-320
| -10% | -$20.1K |
|
|
CCF
2367
DELISTED
Chase Corporation
CCF
| $189K | ﹤0.01% |
1,972
-332
| -14% | -$33.8K |
|
|
DQ
2368
Daqo New Energy
DQ
$996M
| $186K | ﹤0.01% |
6,870
| – | – |
|
|
ADVM
2369
DELISTED
Adverum Biotechnologies
ADVM
| $184K | ﹤0.01% |
1,793
-156
| -8% | -$23.4K |
|
2370
Atlanta Braves Holdings Series A
BATRA
$3.43B
| $184K | ﹤0.01% |
8,804
-473
| -5% | -$9.23K |
|
2371
Travere Therapeutics
TVTX
$5.78B
| $184K | ﹤0.01% |
9,981
-66
| -0.7% | -$1.28K |
|
|
INFN
2372
DELISTED
Infinera Corporation Common Stock
INFN
| $183K | ﹤0.01% |
29,675
-6,574
| -18% | -$46K |
|
2373
Seres Therapeutics
MCRB
$48.9M
| $182K | ﹤0.01% |
321
-41
| -11% | -$13.6K |
|
2374
Camping World
CWH
$653M
| $178K | ﹤0.01% |
5,996
-1,453
| -20% | -$47.4K |
|
2375
Lemonade
LMND
$4.1B
| $178K | ﹤0.01% |
+3,594
| New | +$226K |
|
Similar funds
Legal & General Group's Q3 2020 Portfolio in Review
As of Q3 2020, Legal & General Group held 3,476 positions worth $224B, up 8.1% from $207B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2020: portfolio turnover was 3.2%. Legal & General Group opened 73 new positions and exited 39, leaving the 3,476-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Legal & General Group's largest Q3 2020 buy was AstraZeneca: 305,330 shares worth $33.5M.
- Legal & General Group added most to Zoom in Q3 2020, an estimated $158M increase.
- Legal & General Group's biggest Q3 2020 reduction was Apple, cutting an estimated $486M.
- Legal & General Group fully exited 58.com Inc in Q3 2020, selling an estimated $44.9M.
- Legal & General Group's ten largest holdings make up 22% of its $224B portfolio in Q3 2020.
- Legal & General Group opened 73 new positions and closed 39 in Q3 2020.
- Legal & General Group's portfolio value rose 8.1% quarter-over-quarter to $224B.
Based on Legal & General Group's 13F filing for Q3 2020, filed 13 Nov 2020.